VIVUS Inc. (NASDAQ:VVUS) reports a Q3 revenue of $41,000, consensus $31,000.
Fossil, Inc. (NASDAQ:FOSL) sees a Q4 net sales rise of about 12 percent, with a consensus of $959.41 million.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
CVS Caremark Corporation (NYSE:CVS) consensus is at $3.37. The company stated, “Given the strong third-quarter performance, the anticipated benefit from the accelerated share repurchase program announced in September 2012, and the company’s optimism about retaining at least 60 percent of the prescriptions gained during the impasse between two of its competitors, the company is raising and narrowing its guidance for the full year. The company currently expects to achieve adjusted EPS for 2012 in the range of $3.38 to $3.41, up from its previous range of $3.32 to $3.38…The company reiterated its 2012 free cash flow guidance and expects to generate between $4.6 billion to $4.9 billion for the year. Further, the company confirmed that it expects to generate cash flow from operations in 2012 in the range of $6.2 billion to $6.4 billion. These 2012 guidance estimates include the completion of the accelerated share repurchase agreement of $1.2 billion entered into on September 19.”
Don’t Miss: Election Blues Won’t Keep Zillow Down.